JULIE PENDER: Open Payments
NPI 1326798398 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 104 payments from 23 companies in 2025. Trend: 2023 $2,027 · 2024 $1,920 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $397 |
| ABBVIE INC. | 13 | $233 |
| PFIZER INC. | 14 | $223 |
| AstraZeneca Pharmaceuticals LP | 9 | $155 |
| Axsome Therapeutics, Inc. | 6 | $112 |
| Grifols USA, LLC | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| Lilly USA, LLC | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Abbott Laboratories | 3 | $52 |
Products named: Wegovy, NURTEC ODT, VRAYLAR, JARDIANCE, Prolastin-C Liquid, AIRSUPRA, Auvelity, CAPLYTA.
Industry payments across NC — which companies pay providers there.
